{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:12:20Z","timestamp":1788613940278,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T00:00:00Z","timestamp":1598572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s12029-020-00494-w","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T02:03:23Z","timestamp":1598580203000},"page":"1169-1175","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pediatric Hepatocellular Carcinoma"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5212-218X","authenticated-orcid":false,"given":"Fatma \u0130lknur","family":"Varol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,28]]},"reference":[{"key":"494_CR1","doi-asserted-by":"publisher","first-page":"59","DOI":"10.21037\/tgh.2018.09.05","volume":"3","author":"R Angelico","year":"2018","unstructured":"Angelico R, Grimaldi C, Saffioti MC, Castellano A, Spada M. Hepatocellular carcinoma in children: hepatic resection and liver transplantation. Transl Gastroenterol Hepatol. 2018;3:59. Published 2018 Sep 10. https:\/\/doi.org\/10.21037\/tgh.2018.09.05.","journal-title":"Transl Gastroenterol Hepatol"},{"key":"494_CR2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/JHC.S94008","volume":"4","author":"I Schmid","year":"2017","unstructured":"Schmid I, von Schweinitz D. Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma. 2017;4:15\u201321. Published 2017 Jan 16. https:\/\/doi.org\/10.2147\/JHC.S94008.","journal-title":"J Hepatocell Carcinoma"},{"issue":"35","key":"494_CR3","doi-asserted-by":"publisher","first-page":"3980","DOI":"10.3748\/wjg.v24.i35.3980","volume":"24","author":"R Khanna","year":"2018","unstructured":"Khanna R, Verma SK. Pediatric hepatocellular carcinoma. World J Gastroenterol. 2018;24(35):3980\u201399. https:\/\/doi.org\/10.3748\/wjg.v24.i35.3980.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"494_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.suronc.2007.07.002","volume":"16","author":"RL Meyers","year":"2007","unstructured":"Meyers RL. Tumors of the liver in children. Surg Oncol. 2007;16(3):195\u2013203. https:\/\/doi.org\/10.1016\/j.suronc.2007.07.002.","journal-title":"Surg Oncol"},{"issue":"1","key":"494_CR5","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jpedsurg.2013.09.050","volume":"49","author":"BJ Allan","year":"2014","unstructured":"Allan BJ, Wang B, Davis JS, Parikh PP, Perez EA, Neville HL, et al. A review of 218 pediatric cases of hepatocellular carcinoma. J Pediatr Surg. 2014;49(1):166\u201371. https:\/\/doi.org\/10.1016\/j.jpedsurg.2013.09.050.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"494_CR6","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/mpo.10180","volume":"39","author":"MA Buendia","year":"2002","unstructured":"Buendia MA. Genetic alterations in hepatoblastoma and hepatocellular carcinoma: common and distinctive aspects. Med Pediatr Oncol. 2002;39(5):530\u20135. https:\/\/doi.org\/10.1002\/mpo.10180.","journal-title":"Med Pediatr Oncol"},{"issue":"2","key":"494_CR7","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cld.2015.01.010","volume":"19","author":"D Kelly","year":"2015","unstructured":"Kelly D, Sharif K, Brown RM, Morland B. Hepatocellular carcinoma in children. Clin Liver Dis. 2015;19(2):433\u201347. https:\/\/doi.org\/10.1016\/j.cld.2015.01.010.","journal-title":"Clin Liver Dis."},{"issue":"2","key":"494_CR8","doi-asserted-by":"publisher","first-page":"443-x","DOI":"10.1016\/j.cld.2011.03.011","volume":"15","author":"N Hadzic","year":"2011","unstructured":"Hadzic N, Finegold MJ. Liver neoplasia in children. Clin Liver Dis. 2011;15(2):443-x. https:\/\/doi.org\/10.1016\/j.cld.2011.03.011.","journal-title":"Clin Liver Dis"},{"issue":"2","key":"494_CR9","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","volume":"19","author":"KA McGlynn","year":"2015","unstructured":"McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19(2):223\u201338. https:\/\/doi.org\/10.1016\/j.cld.2015.01.001.","journal-title":"Clin Liver Dis"},{"issue":"12","key":"494_CR10","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1200\/JCO.2002.06.155","volume":"20","author":"HM Katzenstein","year":"2002","unstructured":"Katzenstein HM, Krailo MD, Malogolowkin MH, Ortega JA, Liu-Mares W, Douglass EC, et al. Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children\u2019s Cancer Group intergroup study. J Clin Oncol. 2002;20(12):2789\u201397. https:\/\/doi.org\/10.1200\/JCO.2002.06.155.","journal-title":"J Clin Oncol"},{"key":"494_CR11","doi-asserted-by":"publisher","first-page":"670728","DOI":"10.1155\/2015\/670728","volume":"2015","author":"CS Lau","year":"2015","unstructured":"Lau CS, Mahendraraj K, Chamberlain RS. Hepatocellular carcinoma in the pediatric population: a population based clinical outcomes study involving 257 patients from the Surveillance, Epidemiology, and End Result (SEER) database (1973-2011). HPB Surg. 2015;2015:670728\u201310. https:\/\/doi.org\/10.1155\/2015\/670728.","journal-title":"HPB Surg"},{"issue":"12","key":"494_CR12","doi-asserted-by":"publisher","first-page":"2698","DOI":"10.1016\/j.ejca.2013.04.012","volume":"49","author":"VB Weeda","year":"2013","unstructured":"Weeda VB, Murawski M, McCabe AJ, et al. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience. Eur J Cancer. 2013;49(12):2698\u2013704. https:\/\/doi.org\/10.1016\/j.ejca.2013.04.012.","journal-title":"Eur J Cancer"},{"issue":"12","key":"494_CR13","doi-asserted-by":"publisher","first-page":"2798","DOI":"10.1200\/JCO.2002.06.102","volume":"20","author":"P Czauderna","year":"2002","unstructured":"Czauderna P, Mackinlay G, Perilongo G, Brown J, Shafford E, Aronson D, et al. Hepatocellular carcinoma in children: results of the first prospective study of the International Society of Pediatric Oncology group. J Clin Oncol. 2002;20(12):2798\u2013804. https:\/\/doi.org\/10.1200\/JCO.2002.06.102.","journal-title":"J Clin Oncol"},{"issue":"1","key":"494_CR14","first-page":"13","volume":"8","author":"KL Chan","year":"2002","unstructured":"Chan KL, Fan ST, Tam PK, Chiang AK, Chan GC, Ha SY. Paediatric hepatoblastoma and hepatocellular carcinoma: retrospective study. Hong Kong Med J. 2002;8(1):13\u20137.","journal-title":"Hong Kong Med J"},{"issue":"2","key":"494_CR15","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/ped.12503","volume":"57","author":"AC Zeybek","year":"2015","unstructured":"Zeybek AC, Kiykim E, Soyucen E, et al. Hereditary tyrosinemia type 1 in Turkey: twenty year single-center experience. Pediatr Int. 2015;57(2):281\u20139. https:\/\/doi.org\/10.1111\/ped.12503.","journal-title":"Pediatr Int"},{"key":"494_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13023-014-0107-7","volume":"9","author":"S Mayorandan","year":"2014","unstructured":"Mayorandan S, Meyer U, Gokcay G, et al. Cross-sectional study of 168 patients with hepatorenal tyrosinaemia and implications for clinical practice. Orphanet J Rare Dis. 2014;9:107. Published 2014 Aug 1. https:\/\/doi.org\/10.1186\/s13023-014-0107-7.","journal-title":"Orphanet J Rare Dis"},{"issue":"1\u20132","key":"494_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ymgme.2012.05.022","volume":"107","author":"J Larochelle","year":"2012","unstructured":"Larochelle J, Alvarez F, Bussi\u00e8res JF, Chevalier I, Dallaire L, Dubois J, et al. Effect of nitisinone (NTBC) treatment on the clinical course of hepatorenal tyrosinemia in Qu\u00e9bec. Mol Genet Metab. 2012;107(1\u20132):49\u201354. https:\/\/doi.org\/10.1016\/j.ymgme.2012.05.022.","journal-title":"Mol Genet Metab"},{"issue":"7","key":"494_CR18","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","volume":"12","author":"PS Kishnani","year":"2010","unstructured":"Kishnani PS, Austin SL, Arn P, Bali DS, Boney A, Case LE, et al. Glycogen storage disease type III diagnosis and management guidelines [published correction appears in Genet Med. 2010 Sep;12(9):566]. Genet Med. 2010;12(7):446\u201363. https:\/\/doi.org\/10.1097\/GIM.0b013e3181e655b6.","journal-title":"Genet Med"},{"issue":"3","key":"494_CR19","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2006.09.022","volume":"46","author":"E Demo","year":"2007","unstructured":"Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D, et al. Glycogen storage disease type III-hepatocellular carcinoma a long-term complication? J Hepatol. 2007;46(3):492\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2006.09.022.","journal-title":"J Hepatol"},{"issue":"6","key":"494_CR20","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1399-3046.2011.01528.x","volume":"15","author":"F Romano","year":"2011","unstructured":"Romano F, Stroppa P, Bravi M, Casotti V, Lucianetti A, Guizzetti M, et al. Favorable outcome of primary liver transplantation in children with cirrhosis and hepatocellular carcinoma. Pediatr Transplant. 2011;15(6):573\u20139. https:\/\/doi.org\/10.1111\/j.1399-3046.2011.01528.x.","journal-title":"Pediatr Transplant"},{"issue":"6","key":"494_CR21","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1111\/j.1399-3046.2009.01062.x","volume":"13","author":"H Ismail","year":"2009","unstructured":"Ismail H, Broniszczak D, Kalici\u0144ski P, Markiewicz-Kijewska M, Teisseyre J, Stefanowicz M, et al. Liver transplantation in children with hepatocellular carcinoma. Do Milan criteria apply to pediatric patients? Pediatr Transplant. 2009;13(6):682\u201392. https:\/\/doi.org\/10.1111\/j.1399-3046.2009.01062.x.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"494_CR22","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2010.01.034","volume":"53","author":"L Pawlikowska","year":"2010","unstructured":"Pawlikowska L, Strautnieks S, Jankowska I, Czubkowski P, Emerick K, Antoniou A, et al. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J Hepatol. 2010;53(1):170\u20138. https:\/\/doi.org\/10.1016\/j.jhep.2010.01.034.","journal-title":"J Hepatol"},{"key":"494_CR23","doi-asserted-by":"publisher","unstructured":"Vij M, Shanmugam NP, Reddy MS, Govil S, Rela M. Hepatocarcinogenesis in multidrug-resistant P-glycoprotein 3 deficiency. Pediatr Transplant. 2017;21(3). https:\/\/doi.org\/10.1111\/petr.12889.","DOI":"10.1111\/petr.12889"},{"issue":"4","key":"494_CR24","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ng.2918","volume":"46","author":"M Sambrotta","year":"2014","unstructured":"Sambrotta M, Strautnieks S, Papouli E, et al. Mutations in TJP2 cause progressive cholestatic liver disease. Nat Genet. 2014;46(4):326\u20138. https:\/\/doi.org\/10.1038\/ng.2918.","journal-title":"Nat Genet"},{"issue":"2","key":"494_CR25","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/MPG.0000000000001958","volume":"67","author":"BM Kamath","year":"2018","unstructured":"Kamath BM, Baker A, Houwen R, Todorova L, Kerkar N. Systematic review: the epidemiology, natural history, and burden of Alagille syndrome. J Pediatr Gastroenterol Nutr. 2018;67(2):148\u201356. https:\/\/doi.org\/10.1097\/MPG.0000000000001958.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"494_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1055\/s-0032-1329896","volume":"32","author":"O Bernard","year":"2012","unstructured":"Bernard O, Franchi-Abella S, Branchereau S, Pariente D, Gauthier F, Jacquemin E. Congenital portosystemic shunts in children: recognition, evaluation, and management. Semin Liver Dis. 2012;32(4):273\u201387. https:\/\/doi.org\/10.1055\/s-0032-1329896.","journal-title":"Semin Liver Dis"},{"issue":"8","key":"494_CR27","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1016\/j.cgh.2017.02.006","volume":"15","author":"A Tansel","year":"2017","unstructured":"Tansel A, Katz LH, El-Serag HB, et al. Incidence and determinants of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2017;15(8):1207\u20131217.e4. https:\/\/doi.org\/10.1016\/j.cgh.2017.02.006.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"494_CR28","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1111\/liv.12727","volume":"35","author":"J Pfeiffenberger","year":"2015","unstructured":"Pfeiffenberger J, Mogler C, Gotthardt DN, Schulze-Bergkamen H, Litwin T, Reuner U, et al. Hepatobiliary malignancies in Wilson disease. Liver Int. 2015;35(5):1615\u201322. https:\/\/doi.org\/10.1111\/liv.12727.","journal-title":"Liver Int"},{"issue":"1","key":"494_CR29","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/hep.29086","volume":"67","author":"JK Heimbach","year":"2018","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u201380. https:\/\/doi.org\/10.1002\/hep.29086.","journal-title":"Hepatology."},{"issue":"1","key":"494_CR30","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1399-3046.2007.00777.x","volume":"12","author":"S Sevmis","year":"2008","unstructured":"Sevmis S, Karakayali H, Oz\u00e7ay F, et al. Liver transplantation for hepatocellular carcinoma in children. Pediatr Transplant. 2008;12(1):52\u20136. https:\/\/doi.org\/10.1111\/j.1399-3046.2007.00777.x.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"494_CR31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1111\/j.1399-3046.2005.00395.x","volume":"10","author":"C Arikan","year":"2006","unstructured":"Arikan C, Kilic M, Nart D, Ozgenc F, Ozkan T, Tokat Y, et al. Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome. Pediatr Transplant. 2006;10(1):42\u20137. https:\/\/doi.org\/10.1111\/j.1399-3046.2005.00395.x.","journal-title":"Pediatr Transplant"},{"issue":"1","key":"494_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/hep.29487","volume":"67","author":"LR Roberts","year":"2018","unstructured":"Roberts LR, Sirlin CB, Zaiem F, Almasri J, Prokop LJ, Heimbach JK, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 2018;67(1):401\u201321. https:\/\/doi.org\/10.1002\/hep.29487.","journal-title":"Hepatology."},{"issue":"11","key":"494_CR33","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1016\/j.jpedsurg.2013.05.007","volume":"48","author":"JP McAteer","year":"2013","unstructured":"McAteer JP, Goldin AB, Healey PJ, Gow KW. Hepatocellular carcinoma in children: epidemiology and the impact of regional lymphadenectomy on surgical outcomes. J Pediatr Surg. 2013;48(11):2194\u2013201. https:\/\/doi.org\/10.1016\/j.jpedsurg.2013.05.007.","journal-title":"J Pediatr Surg"},{"issue":"6","key":"494_CR34","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.jamcollsurg.2012.08.001","volume":"215","author":"MN Mavros","year":"2012","unstructured":"Mavros MN, Mayo SC, Hyder O, Pawlik TM. A systematic review: treatment and prognosis of patients with fibrolamellar hepatocellular carcinoma. J Am Coll Surg. 2012;215(6):820\u201330. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2012.08.001.","journal-title":"J Am Coll Surg"},{"issue":"4","key":"494_CR35","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","volume":"11","author":"M Omata","year":"2017","unstructured":"Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int. 2017;11(4):317\u201370. https:\/\/doi.org\/10.1007\/s12072-017-9799-9.","journal-title":"Hepatol Int"},{"issue":"10","key":"494_CR36","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1200\/JCO.2014.60.2250","volume":"34","author":"M Murawski","year":"2016","unstructured":"Murawski M, Weeda VB, Maibach R, Morland B, Roebuck DJ, Zimmerman A, et al. Hepatocellular carcinoma in children: does modified platinum- and doxorubicin-based chemotherapy increase tumor resectability and change outcome? Lessons learned from the SIOPEL 2 and 3 studies. J Clin Oncol. 2016;34(10):1050\u20136. https:\/\/doi.org\/10.1200\/JCO.2014.60.2250.","journal-title":"J Clin Oncol"},{"issue":"24","key":"494_CR37","doi-asserted-by":"publisher","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","volume":"66","author":"L Liu","year":"2006","unstructured":"Liu L, Cao Y, Chen C, Zhang X, McNabola A, Wilkie D, et al. Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5. Cancer Res. 2006;66(24):11851\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-06-1377.","journal-title":"Cancer Res"},{"issue":"4","key":"494_CR38","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/MEG.0b013e328333df23","volume":"22","author":"M Peck-Radosavljevic","year":"2010","unstructured":"Peck-Radosavljevic M, Greten TF, Lammer J, Rosmorduc O, Sangro B, Santoro A, et al. Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2010;22(4):391\u20138. https:\/\/doi.org\/10.1097\/MEG.0b013e328333df23.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"494_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1002\/pbc.23295","volume":"58","author":"I Schmid","year":"2012","unstructured":"Schmid I, H\u00e4berle B, Albert MH, Corbacioglu S, Fr\u00f6hlich B, Graf N, et al. Sorafenib and cisplatin\/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatr Blood Cancer. 2012;58(4):539\u201344. https:\/\/doi.org\/10.1002\/pbc.23295.","journal-title":"Pediatr Blood Cancer"},{"key":"494_CR40","doi-asserted-by":"publisher","unstructured":"Ince V, Akbulut S, Otan E, et al. Liver transplantation for hepatocellular carcinoma: malatya experience and proposals for expanded criteria [published online ahead of print, 2020 Jun 5] [published correction appears in J Gastrointest Cancer. 2020 Jul 8;]. J Gastrointest Cancer. 2020. https:\/\/doi.org\/10.1007\/s12029-020-00424-w.","DOI":"10.1007\/s12029-020-00424-w"},{"issue":"1","key":"494_CR41","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1002\/hep.27191","volume":"60","author":"RH Squires","year":"2014","unstructured":"Squires RH, Ng V, Romero R, Ekong U, Hardikar W, Emre S, et al. Evaluation of the pediatric patient for liver transplantation: 2014 practice guideline by the American Association for the Study of Liver Diseases, American Society of Transplantation and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. Hepatology. 2014;60(1):362\u201398. https:\/\/doi.org\/10.1002\/hep.27191.","journal-title":"Hepatology"},{"issue":"3","key":"494_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1399-3046.2009.01266.x","volume":"14","author":"JJ Guiteau","year":"2010","unstructured":"Guiteau JJ, Cotton RT, Karpen SJ, O'Mahony CA, Goss JA. Pediatric liver transplantation for primary malignant liver tumors with a focus on hepatic epithelioid hemangioendothelioma: the UNOS experience. Pediatr Transplant. 2010;14(3):326\u201331. https:\/\/doi.org\/10.1111\/j.1399-3046.2009.01266.x.","journal-title":"Pediatr Transplant"},{"issue":"12","key":"494_CR43","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1002\/lt.24847","volume":"23","author":"R Vinayak","year":"2017","unstructured":"Vinayak R, Cruz RJ Jr, Ranganathan S, Mohanka R, Mazariegos G, Soltys K, et al. Pediatric liver transplantation for hepatocellular cancer and rare liver malignancies: US multicenter and single-center experience (1981-2015). Liver Transpl. 2017;23(12):1577\u201388. https:\/\/doi.org\/10.1002\/lt.24847.","journal-title":"Liver Transpl"},{"issue":"2","key":"494_CR44","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1002\/lt.24994","volume":"24","author":"U Baumann","year":"2018","unstructured":"Baumann U, Adam R, Duvoux C, Mikolajczyk R, Karam V, D'Antiga L, et al. Survival of children after liver transplantation for hepatocellular carcinoma. Liver Transpl. 2018;24(2):246\u201355. https:\/\/doi.org\/10.1002\/lt.24994.","journal-title":"Liver Transpl"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-020-00494-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-020-00494-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T23:44:08Z","timestamp":1630107848000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-020-00494-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,28]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["494"],"URL":"https:\/\/doi.org\/10.1007\/s12029-020-00494-w","relation":{},"ISSN":["1941-6628","1941-6636"],"issn-type":[{"value":"1941-6628","type":"print"},{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,28]]},"assertion":[{"value":"28 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}]}}